A detailed history of Laird Norton Trust Company, LLC transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 620,735 shares of ANIX stock, worth $1.64 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
620,735
Previous 604,235 2.73%
Holding current value
$1.64 Million
Previous $1.34 Million 46.44%
% of portfolio
0.26%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.21 - $3.48 $36,465 - $57,420
16,500 Added 2.73%
620,735 $1.96 Million
Q1 2024

May 15, 2024

BUY
$3.08 - $5.02 $725,032 - $1.18 Million
235,400 Added 63.82%
604,235 $1.89 Million
Q4 2023

Feb 14, 2024

BUY
$2.85 - $4.19 $1.05 Million - $1.55 Million
368,835 New
368,835 $1.43 Million

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $81.3M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Laird Norton Trust Company, LLC Portfolio

Follow Laird Norton Trust Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laird Norton Trust Company, LLC with notifications on news.